Nucleotide Chemical Synthesis Service
Nucleotides are a class of compounds consisting of three substances: purine or pyrimidine bases, ribose or deoxyribose, and phosphate. Nucleotides are essential tools for regulating gene expression in biomedical and life sciences research and have been developed as gene-targeted therapeutic agents for the treatment of viruses, and tumors. Nucleotide drugs mainly include antisense oligonucleotides, small interfering RNAs, ribozymes, deoxy ribozymes, transgenes, CpG oligonucleotides, transcription factor decoys, and nucleic acid aptamers. Natural nucleotides are easily degraded in vivo, have low specificity, and have toxic side effects. Therefore, drug nucleotides usually carry specific modifying groups, such as thiophosphate diester bond, fluorine substitution, methylation, and locked nucleic acid, etc., to enhance the stability of nucleotides in vivo, improve specificity, and reduce their toxic side effects. Based on the importance of nucleotides to the human body and the prospect of their development in the pharmaceutical industry, a comprehensive study of nucleotides is imminent.
At CD BioGlyco, our nucleotide chemical synthesis service is built upon a foundation of proven methodologies and innovative advancements in synthetic organic chemistry.
Our primary approach for nucleoside diphosphate (NDP) sugars focuses on the efficient formation of the pyrophosphate bond from two monophosphate precursors – a nucleoside monophosphate and a glycosyl phosphate.
This is a cornerstone of our methodology, widely recognized for its stereochemically unambiguous nature and high yields. We utilize nucleoside phosphoromorpholidates, readily prepared in our laboratories via activation with N,N'-dicyclohexylcarbodiimide (DCC) or through Mukaiyama's redox condensation conditions, which can offer simplified purification. This method is highly effective for synthesizing a broad spectrum of natural and non-natural sugar-nucleotides, including those with unusual sugar moieties or fragile anomeric linkages. The use of protected sugar phosphates (e.g., acetylated) is often incorporated to enhance reaction rates and streamline purification.
Complementing the Khorana method, CDI activation is employed for forming pyrophosphate bonds. This versatile method provides comparable yields and reaction times to morpholidate activation in many cases, demonstrating reduced dependency on specific solvents and additives. We strategically apply CDI activation, especially with protected sugar phosphates, to optimize reaction kinetics and product purification.
For certain complex or novel nucleotide structures, we leverage advanced PIII chemistry. This approach involves the condensation of silyl-protected sugar phosphates with phosphoramidite intermediates, followed by in situ oxidation and global deprotection. This methodology is particularly valuable for its impressive yields and operational simplicity, offering a highly efficient route to specific UDP-sugars and their non-natural congeners.
Where applicable, we employ strategies involving the direct glycosylation of a nucleoside diphosphate with an electrophilic glycosyl donor. This method offers significant structural variation due to the commercial availability of numerous NDPs. Our expertise in controlling stereoselectivity, including the use of neighboring group participation from protecting groups (e.g., acetate or benzoate at position 2) on glycosyl donors, allows us to achieve pure anomeric products for specific sugars like α-D-mannose or β-L-fucose.
Nucleotide production methods are mainly divided into chemical and biological (Microbial or Enzymatic) production. CD BioGlyco has many years of experience and is well-versed in the use of chemical methods.
At CD BioGlyco, we produce nucleotides mainly from nucleosides in the presence of phosphorylating reagents. In this route, the complex steps of protection and deprotection are avoided, subsequent purification is simple, and a high yield (90%-95%) is achieved overall. We also offer a wide range of phosphorylation reagents to meet our clients' production needs.
In addition, we offer the following routes to produce nucleotides:
In addition to the production of nucleotides, we also provide structural characterization of nucleotides. We have HPLC, NMR, IR, and other professional techniques for comprehensive analysis of products.
We meticulously source or synthesize all necessary starting materials, including nucleoside monophosphates, glycosyl phosphates, and appropriate protecting group reagents. This stage often involves the in-house preparation of activated precursors, such as nucleoside phosphoromorpholidates, or silyl-protected sugar phosphates, ensuring high quality and reactivity.
This is the central step where the key phosphodiester or pyrophosphate bond is formed. Depending on the chosen strategy, this could involve Khorana-type coupling, CDI activation, or phosphoramidite chemistry. Reactions are conducted under strictly controlled conditions, often anhydrous, to maximize yield and prevent unwanted side reactions or hydrolysis.
Following the coupling, any necessary protecting groups are selectively removed under mild conditions to yield the free nucleotide monomer. The crude product undergoes rigorous purification using advanced chromatographic techniques to ensure the highest possible purity, addressing the low solubility and polar nature of these compounds.
The final purified nucleotide monomer undergoes comprehensive quality control analysis. This includes techniques such as NMR spectroscopy for structural confirmation, mass spectrometry for molecular weight verification, and high-performance liquid chromatography for purity assessment and quantification. A detailed certificate of analysis is provided with each delivery.
DOI.: 10.3390/molecules25235755
Journal: Molecules
IF: 4.6
Published: 2020
Results: This review comprehensively explores the multifaceted roles of nucleotide sugars, essential building blocks for carbohydrate and glycoconjugate biosynthesis in all living organisms. It covers their biological significance in mammalian, plant, and bacterial glycosylation pathways, detailing their diverse structures and biosynthetic routes. The article delves into the mechanisms of enzymes utilizing nucleotide sugars (glycosyltransferases, phosphoglycosyltransferases, hydrolases) and analyzes their inherent chemical reactivity and decomposition pathways in solution. It also reviews chemical and enzymatic synthesis methods for natural and modified nucleotide sugars, including chemoenzymatic cascades. The work emphasizes the importance of understanding these molecules for developing therapeutic strategies (e.g., enzyme inhibitors, vaccines) and efficient synthetic routes for oligosaccharides and glycoconjugates.
Building on our foundation of precision nucleotide monomer synthesis, we extend our expertise to Chemical-based Oligonucleotide Synthesis Service through two strategically optimized approaches:
CD BioGlyco has many years of research experience in the production of nucleotides. We have a specialized research team that has developed a variety of research protocols in the production of nucleotides. We provide custom nucleotide production solutions to our clients around the world, providing scientific assistance in the development and utilization of nucleotide resources. If you are interested in our services, please feel free to contact us.
Reference
